Focusing on IFSCC: Bloomage Takes the Stage at the 35th IFSCC Congress, Leading a New Wave in Cosmetic Science

Recently, the 35th International Federation of Societies of Cosmetic Chemists (IFSCC) Congress successfully concluded at the Palais des Festivals in Cannes, France. The theme of this year’s congress was “The Future is Science.”

IFSCC is an international organization dedicated to advancing global cooperation in cosmetic science and technology. It brings together 51 member societies from 81 countries, representing more than 16,000 individual members. The International Federation of Societies of Cosmetic Chemists is dedicated to advancing cosmetic science through international cooperation, providing a platform for learning, recognition, and inspiration.

At this congress, Bloomage showcased its outstanding scientific research capabilities. A total of eight posters from Bloomage were selected and presented during the event, earning wide recognition and high praise from experts and scholars in attendance. These posters not only demonstrated the company’s depth and breadth of exploration at the forefront of cosmetic science, but also injected strong scientific momentum into technological innovation, paving broader pathways for future breakthroughs. 

Among them, Ms. Dailin Xu, R&D Engineer at Bloomage, delivered a podium presentation on ectoine research titled: “Skin Issues Management Under in Vitro Human Chronic Stress 3D Skin Equivalents Through Treatment With Ectoin: By Modulating the Glucocorticoid Receptor Chaperone HSP70-HSP90-Complexes.”Ms. Xu introduced a newly developed full-thickness human 3D reconstructed skin equivalent (RHE) model, which demonstrated valuable application potential in screening stress-relief active substances. The study highlighted that tetrahydro-pyrimidine (ectoine) exhibits remarkable anti-stress efficacy by modulating the HSP70-HSP90 protein complex.

Chronic stress disrupts the delicate balance of stress adaptation in the human body, causing glucocorticoids (GCs) to exert harmful effects that lead to systemic endocrine dysregulation, epidermal barrier impairment, and dermal structural alterations. Bloomage’s chronic stress human skin equivalent model—highly reproducible, scalable, and pathophysiologically consistent with GC-induced skin lesions in humans—provides a translational platform for mechanistic research and therapeutic innovation. By confirming that ectoine modulates the molecular chaperones HSP70 and HSP90 within the GC signaling axis, this study revealed ectoine’s therapeutic potential in alleviating stress-exacerbated skin dysfunction, underscoring its value in preclinical validation of stress-targeted skin interventions.

In addition to the posters and podium presentation, Bloomage also showcased a series of innovative products and solutions at the congress. These included advances in biological sunscreen, cell-level skincare, skincare-infused cosmetics, hair and scalp care, bioactive oral care, and delivery platform, based on sodium surfactin. These achievements not only demonstrate Bloomage’s solid foundation in cosmetic science but also provide customers with comprehensive, professional, and integrated solutions.